Skip to main content

and
  1. Article

    Open Access

    Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia

    Mixed phenotype acute leukemia (MPAL), a rare subgroup of leukemia characterized by blast cells with myeloid and lymphoid lineage features, is difficult to diagnose and treat. A better characterization of MPAL...

    Hope L. Mumme, Sunil S. Raikar, Swati S. Bhasin, Beena E. Thomas in Genome Medicine (2023)

  2. Article

    Open Access

    Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia

    Acute myeloid leukemia (AML) microenvironment exhibits cellular and molecular differences among various subtypes. Here, we utilize single-cell RNA sequencing (scRNA-seq) to analyze pediatric AML bone marrow (B...

    Hope Mumme, Beena E. Thomas, Swati S. Bhasin, Upaasana Krishnan in Nature Communications (2023)

  3. Article

    Open Access

    Author Correction: YB1 modulates the DNA damage response in medulloblastoma

    Leon F. McSwain, Claire E. Pillsbury, Ramona Haji‑Seyed‑Javadi in Scientific Reports (2023)

  4. Article

    Open Access

    YB1 modulates the DNA damage response in medulloblastoma

    Y-box binding protein 1 (YBX1 or YB1) is a therapeutically relevant oncoprotein capable of RNA and DNA binding and mediating protein–protein interactions that drive proliferation, stemness, and resistance to plat...

    Leon F. McSwain, Claire E. Pillsbury, Ramona Haji-Seyed-Javadi in Scientific Reports (2023)

  5. Article

    Open Access

    B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12

    Immunotherapies have revolutionized the treatment of B-cell acute lymphoblastic leukemia (B-ALL), but the duration of responses is still sub-optimal. We sought to identify mechanisms of immune suppression in B...

    Rae Hunter, Kathleen J. Imbach, Cheng**g Zhou, Jodi Dougan in Scientific Reports (2022)

  6. No Access

    Article

    Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells

    While targeting CD19+ hematologic malignancies with CAR T cell therapy using single chain variable fragments (scFv) has been highly successful, novel strategies for applying CAR T cell therapy with other tumor...

    Jaquelyn T. Zoine, Chengyu Prince, Jamie Y. Story, Gianna M. Branella in Gene Therapy (2022)

  7. Article

    Open Access

    Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia

    The incidence of obesity is rising with greater than 40% of the world’s population expected to be overweight or suffering from obesity by 2030. This is alarming because obesity increases mortality rates in pat...

    Miyoung Lee, Jamie A. G. Hamilton, Ganesh R. Talekar in Nature Communications (2022)

  8. No Access

    Article

    Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts

    Germline genetic variants contribute to a substantial proportion of cases of cancer in childhood. The purpose of this review is to describe two emerging pediatric cancer predisposition syndromes, including pub...

    Sarah G. Mitchell, Bojana Pencheva, Christopher C. Porter in Current Oncology Reports (2019)

  9. Article

    Open Access

    Efficient identification of mutations that potentially confer treatment resistance through computational derivation

    Christy M Gearheart, James R Lambert, Christopher C Porter in BMC Bioinformatics (2015)

  10. No Access

    Article

    Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

    Jorge Di Paola, Christopher Porter, Walter Kahr and colleagues report germline mutations in the transcriptional repressor gene ETV6 in three families with thrombocytopenia and elevated red blood cell volume. All ...

    Leila Noetzli, Richard W Lo, Alisa B Lee-Sherick, Michael Callaghan in Nature Genetics (2015)

  11. No Access

    Article

    ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53

    A genetic synthetic lethal screen reveals that ATM and MET kinases promote cell survival upon activation of p53 with Nutlin-3, and these survival pathways act in parallel to canonical cell cycle arrest and apo...

    Kelly D Sullivan, Nuria Padilla-Just, Ryan E Henry in Nature Chemical Biology (2012)